Teligent, Inc. (TLGT): Price and Financial Metrics


Teligent, Inc. (TLGT)

Today's Latest Price: $1.01 USD

0.01 (-0.98%)

Updated Jan 19 4:00pm

Add TLGT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 483 in Biotech

See all "A" rated Strong Buy stocks

TLGT Stock Summary

  • Equity multiplier, or assets relative to shareholders' equity, comes in at -6.73 for Teligent Inc; that's greater than it is for only 2.59% of US stocks.
  • In terms of volatility of its share price, TLGT is more volatile than 97.41% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for TLGT comes in at -83.83% -- higher than that of only 3.65% of stocks in our set.
  • Stocks that are quantitatively similar to TLGT, based on their financial statements, market capitalization, and price volatility, are SSRM, HL, CIG, ENDP, and TWER.
  • TLGT's SEC filings can be seen here. And to visit Teligent Inc's official web site, go to www.teligent.com.

TLGT Stock Price Chart Interactive Chart >

Price chart for TLGT

TLGT Price/Volume Stats

Current price $1.01 52-week high $6.46
Prev. close $1.02 52-week low $0.46
Day low $0.97 Volume 1,978,540
Day high $1.05 Avg. volume 4,865,015
50-day MA $0.70 Dividend yield N/A
200-day MA $1.91 Market Cap 21.97M

Teligent, Inc. (TLGT) Company Bio


Teligent Inc. is a specialty generic pharmaceutical company developing, manufacturing, and marketing topical formulations in the United States. The company was founded in 1977 and is based in Buena, New Jersey.


TLGT Latest News Stream


Event/Time News Detail
Loading, please wait...

TLGT Latest Social Stream


Loading social stream, please wait...

View Full TLGT Social Stream

Latest TLGT News From Around the Web

Below are the latest news stories about Teligent Inc that investors may wish to consider to help them evaluate TLGT as an investment opportunity.

Teligent (NASDAQ:TLGT) Releases Earnings Results, Misses Expectations By $0.61 EPS

Teligent (NASDAQ:TLGT) released its quarterly earnings results on Wednesday. The company reported ($2.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.48) by ($0.61), Fidelity Earnings reports. NASDAQ TLGT opened at $0.75 on Friday. The stock has a market capitalization of $4.04 million, a price-to-earnings ratio of -0.08 and a beta of […]

Transcript Daily | January 1, 2021

Teligent EPS beats by $1.06, beats on revenue

Teligent (TLGT): Q3 Non-GAAP EPS of -$0.42 beats by $1.06; GAAP EPS of -$0.08 beats by $2.00.Revenue of $14.34M (-22.4% Y/Y) beats by $0.77M.Press Release...

Seeking Alpha | December 31, 2020

$TLGT PT 3-5.75 and higher by Jan 5th to Jan 21st for NASDAQ:TLGT by Rocky88888888888

Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid …

TradingView | December 14, 2020

Why Is It Moving? Analyzing The Upward Movement in Teligent's Stock Today

The Price And Volume Action In Teligent's Stock Today Teligent (NASDAQ: TLGT) is currently up 67.3% to a price of $1.12. Monday the stock has been …

Benzinga | December 14, 2020

The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 2) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Immunovant Inc (NASDAQ: IMVT ) United Therapeutics Corporation (NASDAQ: UTHR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 2) AEterna Zentaris Inc. (NASDAQ: AEZS ) Aikido Pharma Inc (NASDAQ: AIKI ) Artelo Biosciences Inc (NASDAQ: ARTL ) Avita Therapeutics Inc (NASDAQ: RCEL ) Benitec Biopharma Inc (NASDAQ: BNTC ) BioCardia Inc (NASDAQ: BCDA ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Catabasis Pharmaceuticals Inc (NASDAQ: CATB ) Celsion Corporation (NASDAQ: CLSN ) Codiak BioSciences Inc (NASDAQ: CDAK ) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) Entasis T...

Benzinga | November 3, 2020

Read More 'TLGT' Stories Here

TLGT Price Returns

1-mo 23.37%
3-mo -3.35%
6-mo -57.38%
1-year N/A
3-year -97.10%
5-year -98.55%
YTD 34.67%
2020 -82.39%
2019 -68.91%
2018 -62.26%
2017 -45.08%
2016 -25.73%

Continue Researching TLGT

Want to see what other sources are saying about Teligent Inc's financials and stock price? Try the links below:

Teligent Inc (TLGT) Stock Price | Nasdaq
Teligent Inc (TLGT) Stock Quote, History and News - Yahoo Finance
Teligent Inc (TLGT) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8307 seconds.